Anton, is there a reason that there are so few nootropics/smart drugs? Maybe worry over regulation? I know we talked about this about a year ago, my Facebook post asking about it got some attention, and I see a few on the Desires list.
Stuff like the racetams, bromantane, nicotine, modafinil, etc.
With the professional plans, do the invited patients have full access to the ICs and complexes, or only access to the IC suggests that I would create for them?